ArticleNeurourology and urodynamics2025
Critical Appraisal of Guidelines for Daytime Urinary Incontinence in Children: Comparison of Recommendations on Treatment.
Article in Neurourology and urodynamics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsThis study aimed to compare the recommendations on therapy from currently available guidelines on non-neurogenic daytime urinary incontinence (DUI) in children.
methodsWe conducted a systematic search for guidelines on non-neurogenic DUI in children. We extracted the therapy recommendations from all the guidelines for a descriptive comparison.
resultsEight guidelines were included. All guidelines advise urotherapy as the first step of treatment in children with DUI. They all agree on the importance of addressing co-existing bowel dysfunction and urinary tract infections. Neuromodulation was recommended as an early treatment modality in three guidelines, while the others reserve it for special cases (n = 2) or do not mention it at all (n = 3). Pharmacotherapy with anticholinergics is often recommended, sometimes when urotherapy is insufficient, and by some guidelines simultaneously. The use of newer beta-3-agonists was only mentioned by recently (2019 and 2021) published guidelines. Only half of the guidelines mentioned the level of evidence with their recommendations, and when mentioned, the quality of the evidence is generally low.
conclusionOverall, the recommendations for treating non-neurogenic DUI in children are generally consistent, with all the guidelines endorsing urotherapy as the initial treatment. However, differences exist regarding additional treatments such as neuromodulation and pharmacotherapy, both areas of active research with evolving insights. The observed differences can be explained by the publication date of the guidelines and the target audience. The evidence supporting the recommendations is generally of low quality, indicating a need for further research in the field of DUI in children.
trial registrationAs this is a review, no clinical trial registration was conducted. The review protocol has been registered in PROSPERO (CRD42021149059).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.